CBC News -- Landmark legal action challenging a patent over breast cancer gene BRCA1 is being launched in Australia Tuesday. The Australian action follows a lawsuit in the United States against patent holder Myriad Genetics.
CBC News -- Landmark legal action challenging a patent over breast cancer gene BRCA1 is being launched in Australia Tuesday. The Australian action follows a lawsuit in the United States against patent holder Myriad Genetics.